A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda

被引：0
|
作者：
Solomon J. Lubinga
Byamah B. Mutamba
Angelo Nganizi
Joseph B. Babigumira
机构：
[1] University of Washington,Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy
[2] University of Washington,Global Medicines Program, Department of Global Health
[3] Butabika National Referral Hospital for Mental,undefined
[4] Neurological and Substance Abuse Disorders,undefined
[5] Kadic Hospital,undefined
来源：
Applied Health Economics and Health Policy | 2015年 / 13卷
关键词：
Schizophrenia; Haloperidol; Risperidone; Olanzapine; Quetiapine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：493 / 506
页数：13
相关论文
共 50 条
  • [11] Decision analysis model evaluating the cost-effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophrenia
    Bounthavong, Mark
    Okamoto, Mark P.
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2007, 13 (03) : 453 - 460
  • [12] Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
    O'Day, Ken
    Rajagopalan, Krithika
    Meyer, Kellie
    Pikalov, Andrei
    Loebel, Antony
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 459 - 470
  • [13] COST-EFFECTIVENESS IN THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA
    GOLDBERG, D
    ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 : 89 - 92
  • [14] Schizophrenia costs and treatment cost-effectiveness
    Knapp, M
    ACTA PSYCHIATRICA SCANDINAVICA, 2000, 102 : 15 - 18
  • [15] Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
    Sylvain Druais
    Agathe Doutriaux
    Magali Cognet
    Annabelle Godet
    Christophe Lançon
    Pierre Levy
    Ludovic Samalin
    Pascal Guillon
    PharmacoEconomics, 2016, 34 : 363 - 391
  • [16] Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia
    Phanthunane P.
    Vos T.
    Whiteford H.
    Bertram M.
    Cost Effectiveness and Resource Allocation, 9 (1)
  • [17] Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia
    Ascher-Svanum, Haya
    Stensland, Michael D.
    Peng, Xiaomei
    Faries, Douglas E.
    Stauffer, Virginia L.
    Osuntokun, Olawale O.
    Kane, John M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) : 115 - 122
  • [18] An extended cost-effectiveness analysis of schizophrenia treatment in India under universal public finance
    Raykar, Neha
    Nigam, Aditi
    Chisholm, Dan
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2016, 14
  • [19] Cost-effectiveness of aripiprazole orally disintegrating tablets in the treatment of schizophrenia in China
    Lin, Ziyi
    Xuan, Jianwei
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (05) : 549 - 558
  • [20] Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China
    Zhao, Jingping
    Jiang, Kaida
    Li, Qingwei
    Zhang, Yanlei
    Cheng, Yan
    Lin, Ziyi
    Xuan, Jianwei
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (05) : 439 - 446
12345